Eric Scholar
- Physiology top 5%
- Adenosine and Purinergic Signaling 3
- Oncology top 5%
- Immunology top 10%
- Immune cells in cancer 2
- Molecular Biology top 10%
- Biochemical and Molecular Research 10
- Cancer therapeutics and mechanisms 2
- Hematology top 10%
-
- Neuropeptides and Animal Physiology 3
-
- HIV/AIDS drug development and treatment 3
-
- Acute Lymphoblastic Leukemia research 3
-
- Neonatal Health and Biochemistry 2
- Co-authors
- Amit AroraJames E. TalmadgeMoses DonkorPeter A. CalabresiRobert E. ParksMyron L. ToewsPhyllis R. BrownWilliam B. Pratt
- Cited by
- PhysiologyOncologyImmunology
- Journals
- Biochemical Pharmacology (6 papers)Cancer Letters (3 papers)Nutrition and Cancer (2 papers)
- Partner nations
- United StatesItaly
In The Last Decade
Eric Scholar
27 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Physiology 107
- Oncology 581
- Immunology 279
- Molecular Biology 893
- Hematology 141
Countries citing papers authored by Eric Scholar
This map shows the geographic impact of Eric Scholar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Scholar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Scholar more than expected).
Fields of papers citing papers by Eric Scholar
This network shows the impact of papers produced by Eric Scholar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Scholar. The network helps show where Eric Scholar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Scholar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 21 | |
| 2 | 2009 | 45 | |
| 3 | 2007 | 233 | |
| 4 | Role of Tyrosine Kinase Inhibitors in Cancer Therapybreakdown → | 2005 | 785 |
| 5 | Fluoroquinolines: Past, Present and Future of a Novel Group of Antibacterial Agents | 2003 | 11 |
| 6 | 2000 | 49 | |
| 7 | 1999 | 3 | |
| 8 | 1994 | 58 | |
| 9 | 1991 | 24 | |
| 10 | 1989 | 19 | |
| 11 | 1989 | 23 | |
| 12 | 1987 | 2 | |
| 13 | Isolation and preliminary characterization of an Adriamycin-resistant murine fibrosarcoma cell line. | 1983 | 38 |
| 14 | 1982 | 6 | |
| 15 | 1979 | 12 | |
| 16 | 1973 | 8 | |
| 17 | 1973 | 63 | |
| 18 | 1973 | 40 | |
| 19 | Synergistic effect of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside on the levels of adenine nucleotides of Sarcoma 180 cells. | 1972 | 37 |
| 20 | 1971 | 52 |
About Eric Scholar
Eric Scholar is a scholar working on Physiology, Molecular Biology and Oncology, having authored 27 papers that have together received 1.8k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (10 papers), Neuropeptides and Animal Physiology (3 papers), HIV/AIDS drug development and treatment (3 papers), Adenosine and Purinergic Signaling (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Neonatal Health and Biochemistry (2 papers), Cancer therapeutics and mechanisms (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Physiology (107 citations), Oncology (581 citations) and Immunology (279 citations). Eric Scholar has collaborated with scholars based in United States and Italy. Frequent co-authors include Amit Arora, James E. Talmadge, Moses Donkor, Peter A. Calabresi, Robert E. Parks, Myron L. Toews, Phyllis R. Brown, William B. Pratt, Khushboo Agarwal and R. P. Agarwal. Their work appears in journals such as Biochemical Pharmacology, Cancer Letters, Nutrition and Cancer, Cancer and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.